Heart device implant using ultrasound probe inside the heart
Part of Heart & circulation clinical trials.
This trial studies a procedure to implant a Watchman device using a tiny ultrasound probe placed inside the heart, avoiding a probe in the throat. It may help patients with atrial fibrillation who need to reduce stroke risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are eligible for a standard Watchman device implant as determined by your doctor.
- You are not currently taking part in another clinical trial.
- You can have a transesophageal echocardiogram (ultrasound probe in the throat) if needed during the procedure.
- You are not having a separate heart ablation procedure at the same time.
- You have not had a prior left atrial appendage closure or ligation procedure.
- You do not have a closure device for a hole in the heart (PFO or ASD) that would make the implant difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new 3D/4D ultrasound technology that creates detailed images of the heart during a left atrial appendage closure procedure. The goal is to see if this imaging tool helps doctors perform the procedure more safely and accurately.
This trial tests a new imaging method (4D-ICE) used alongside a standard ultrasound (TEE) during a heart procedure to close the left atrial appendage, a small pouch in the heart where clots can form in people with atrial fibrillation. The goal is to see if the new method makes the procedure safer and more precise.
This study tests a procedure that seals off the left atrial appendage (a small heart pouch) to help prevent stroke in people with atrial fibrillation. You may be considered if your stroke risk is high and you are already on blood-thinner medicine.
This trial compares a heart device that can help prevent blood clots in the heart (called LAAO) versus long-term blood thinners for people who have atrial fibrillation and recently had a stent placed. It aims to see which approach better prevents stroke and related blood-clot problems while keeping side effects manageable.
This study looks at whether using a special steerable tube (called a sheath) helps doctors close the left atrial appendage more successfully with the Amplatzer Amulet device. This procedure is done to reduce stroke risk in people with atrial fibrillation.
This trial tests a new device called ENDOMATIC SEPIOLA that closes a small pouch in your heart (the left atrial appendage) to lower your stroke risk. It is a non-surgical option for people with atrial fibrillation who cannot take blood thinners.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.